Lv3
388 积分 2025-05-18 加入
Effectiveness and safety of upadacitinib for inflammatory bowel disease: A systematic review and meta-analysis of RCT and real-world observational studies
5天前
已完结
Biosimilar Switching in IBD: Safety, Efficacy, and Immunogenicity in 10,812 Patients � A Systematic Review and Meta-analysis
5天前
已关闭
Rituximab for connective tissue disease‐associated interstitial lung disease: A systematic review and meta‐analysis
19天前
已完结
Effects of cyclophosphamide and rituximab in patients with connective tissue diseases with severe interstitial lung disease
25天前
已完结
The impact of vedolizumab therapy on extraintestinal manifestations in patients with inflammatory bowel disease: A systematic review and meta‐analysis
1个月前
已完结
Rituximab for connective tissue disease‐associated interstitial lung disease: A systematic review and meta‐analysis
1个月前
已完结
Rituximab versus intravenous cyclophosphamide in patients with connective tissue disease-associated interstitial lung disease in the UK (RECITAL): a double-blind, double-dummy, randomised, controlled, phase 2b trial
1个月前
已完结
Rituximab Treatment in Adult Patients With Idiopathic Inflammatory Myositis
1个月前
已完结
Management and outcomes of interstitial lung disease associated with anti-synthetase syndrome: a systematic literature review
1个月前
已完结
Rituximab Treatment in Adult Patients With Idiopathic Inflammatory Myositis
3个月前
已完结
皖公网安备34019202002308
